Does RETIFANLIMAB Cause Off label use? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Off label use have been filed in association with RETIFANLIMAB (ZYNYZ). This represents 6.3% of all adverse event reports for RETIFANLIMAB.
6
Reports of Off label use with RETIFANLIMAB
6.3%
of all RETIFANLIMAB reports
4
Deaths
3
Hospitalizations
How Dangerous Is Off label use From RETIFANLIMAB?
Of the 6 reports, 4 (66.7%) resulted in death, 3 (50.0%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RETIFANLIMAB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does RETIFANLIMAB Cause?
Diarrhoea (23)
Nausea (14)
Neutrophil count decreased (12)
White blood cell count decreased (12)
Disease progression (11)
Neutropenic sepsis (11)
Condition aggravated (9)
Pulmonary embolism (9)
Pyrexia (9)
Asthenia (8)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)